Clinical Pathophysiology of Nephrolithiasis

$276,699P01FY2014DKNIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 39340639 Paper 39281877 Paper 38251931 Paper 37823200 Paper 37530089 Paper 37468583 Paper 37468493 Paper 37256909 Paper 36867975 Paper 35976425 Paper 35926776 Paper 35912993 Paper 35133089 Paper 34915736 Paper 34825513 Paper 34321982 Paper 34091721 Paper 34042292 Paper 33765680 Paper 33403824 Paper 33026465 Paper 32900691 Paper 32561654 Paper 32405588 Paper 32149733 Paper 32066273 Paper 31880949 Paper 31863294 Paper 31790303 Paper 31760802 Paper 31017011 Paper 30793930 Paper 30610358 Paper 30066583 Paper 29392338 Paper 29357436 Paper 29279874 Paper 29126251 Paper 28980082 Paper 28822796 Paper 28784428 Paper 28154201 Paper 27913855 Paper 27824271 Paper 27612997 Paper 27549355 Paper 27452364 Paper 27038771 Paper 26956131 Paper 26924944 Paper 26608788 Paper 26555954 Paper 26526044 Paper 26414908 Paper 26376133 Paper 25988516 Paper 25947170 Paper 25656372 Paper 25615853 Paper 25108546 Paper 25096802 Paper 25014576 Paper 24657667 Paper 24478243 Paper 24089413 Paper 23917165 Paper 23881525 Paper 23863465 Paper 23720347 Paper 23438422 Paper 23228113 Paper 23177635 Paper 23159588 Paper 23159272 Paper 22976521 Paper 22698623 Paper 22612388 Paper 22591962 Paper 22358148 Paper 22337820 Paper 22245295 Paper 21952643 Paper 21825103 Paper 21123489 Paper 21063698 Paper 21057942 Paper 20818905 Paper 20818325 Paper 20719342 Paper 20652560 Paper 20632168 Paper 20625890 Paper 20623223 Paper 20428098 Paper 20411383 Paper 20132593 Paper 20035974 Paper 19814580 Paper 19710630 Paper 19640901

Abstract

PROJECT SUMIVIARY (See instructions): Our prior work has shown that calcium (Ca) stone formers (SF) with idiopathic hypercalciuria (IH) have decreased renal tubule Ca reabsorption which is most marked after meals. Proximal tubule (PT) Ca reabsorption appears to be decreased in Ca oxalate SF (ICSF) but not Ca phosphate (CaP) SF (IPSF), meaning that other tubule sites must be affected in IPSF. ICSF and IPSF also differ in the site of mineral deposition in their kidneys - interstitial plaque vs. tubule plugs. These experiments use a Gerneral Clinical Research Center protocol to study the sites of abnormal Ca reabsorption in ICSF and IPSF compared with normals (N). We hypothesize that TAL Ca reabsorption will be increased in ICSF, fostering plaque via vas wash-down. We use furosemide (Fur) blockade of thick ascending limb (TAL) transport to confirm the decreased PT transport discovered using lithium clearnace (Aim 1.1a), and to gauge absolute TAL Ca reabsorption (Aim 1.1b). We also predict that TAL Ca reabsorption is decreased in IPSF, and also results in decreased TAL bicarbonate absorption, resulting in increased urine pH and CaP SS which promotes tubule plugging (Aim 1.1c). We test several potential signallers of renal Ca reabsorption for a relationship to Ca transport, looking for dyssynchrony with transport changes in a time resolved protocol, and differences in regression of signaller levels and Ca reabsorption between ICSF, IPSF, and N (Aim 1.2a,b), seeking potential drug targets. Thiazide (TZ) is a main treatment for Ca stone prevention and lowers urine Ca; animal experiments suggest that PT Ca reabsorption is increased with TZ. If PT reabsorption is increased by TZ in humans, it may reduce plaque formation as well as stone recurrence (Aim 1.3). Calcitriol levels are elevated in many Ca SF, and administration of calcitriol to N in non-hypercalcemic doses can reproduce findings of IH, including inability to conserve Ca on a low Ca diet. We will test whether calcitriol can decrease PT Ca reabsorption as seen in IH (Aim 1.4). All SF studied in Project 1 will have biopsy and tissue studies in Projects 2 and 3, so results of physiology studies can be combined with histopathologic data to test project aims (PI-6) relating Ca transport to tissue Ca levels, mineral deposits, transporters and receptors.

View original record on NIH RePORTER →